Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AL Amyloidosis (AL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524634
What this trial is testing

Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Case Comprehensive Cancer Center 64
Not applicableStudy completedNCT02055534
What this trial is testing

Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 144
Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing

JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 240
Early research (Phase 1)Study completedNCT01409148
What this trial is testing

Radioimmunoimaging of AL Amyloidosis

Who this might be right for
AL Amyloidosis
University of Tennessee 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687004
What this trial is testing

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification

Who this might be right for
Multiple Myeloma (MM)
Institute of Hematology & Blood Diseases Hospital, China 50
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Study completedNCT00621400
What this trial is testing

Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

Who this might be right for
Amyloidosis
Nantes University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT01194791
What this trial is testing

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

Who this might be right for
Primary Systemic Amyloidosis
PETHEMA Foundation 30
Testing effectiveness (Phase 2)Study completedNCT05199337
What this trial is testing

Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

Who this might be right for
AmyloidosisAL Amyloidosis
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT03236792
What this trial is testing

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Who this might be right for
AL Amyloidosis
Icahn School of Medicine at Mount Sinai 28
Not applicableWithdrawnNCT06769555
What this trial is testing

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Study completedNCT04131309
What this trial is testing

Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis, Stage 3B
Stichting European Myeloma Network 40
Testing effectiveness (Phase 2)Ended earlyNCT03154047
What this trial is testing

Study in Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 80
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Not applicableStudy completedNCT02111538
What this trial is testing

Body Composition in Systemic Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 127
Testing effectiveness (Phase 2)Looking for participantsNCT05145816
What this trial is testing

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Who this might be right for
AL AmyloidosisAmyloidosis
University of Texas Southwestern Medical Center 37
Not applicableLooking for participantsNCT06894290
What this trial is testing

International Cardiac Amyloidosis Registry

Who this might be right for
Cardiac Amyloidosis
Leiden University Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT00679367
What this trial is testing

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 16
Very early researchLooking for participantsNCT07085559
What this trial is testing

Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)AL Amyloidosis (AL)
Anhui Provincial Hospital 36
Next Page